These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21737806)

  • 1. Atherogenic dyslipidemia in patients with transient ischemic attack.
    Sirimarco G; Deplanque D; Lavallée PC; Labreuche J; Meseguer E; Cabrejo L; Guidoux C; Olivot JM; Abboud H; Lapergue B; Klein IF; Mazighi M; Touboul PJ; Bruckert E; Amarenco P
    Stroke; 2011 Aug; 42(8):2131-7. PubMed ID: 21737806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenic Dyslipidemia and Residual Vascular Risk After Stroke or Transient Ischemic Attack.
    Hoshino T; Ishizuka K; Toi S; Mizuno T; Nishimura A; Takahashi S; Wako S; Kitagawa K
    Stroke; 2022 Jan; 53(1):79-86. PubMed ID: 34470483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
    Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
    Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients.
    Sirimarco G; Labreuche J; Bruckert E; Goldstein LB; Fox KM; Rothwell PM; Amarenco P;
    Stroke; 2014 May; 45(5):1429-36. PubMed ID: 24736236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
    Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
    Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get with the Guidelines-Stroke 2003 to 2012.
    Saposnik G; Fonarow GC; Pan W; Liang L; Hernandez AF; Schwamm LH; Smith EE;
    Stroke; 2014 Nov; 45(11):3343-51. PubMed ID: 25300975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of dyslipidemia and associated risk factors in Turkish adults.
    Bayram F; Kocer D; Gundogan K; Kaya A; Demir O; Coskun R; Sabuncu T; Karaman A; Cesur M; Rizzo M; Toth PP; Gedik V
    J Clin Lipidol; 2014; 8(2):206-16. PubMed ID: 24636181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria.
    Olamoyegun MA; Oluyombo R; Asaolu SO
    Ann Afr Med; 2016; 15(4):194-199. PubMed ID: 27853034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Amarenco P; Goldstein LB; Callahan A; Sillesen H; Hennerici MG; O'Neill BJ; Rudolph AE; Simunovic L; Zivin JA; Welch KM;
    Atherosclerosis; 2009 Jun; 204(2):515-20. PubMed ID: 18962621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
    Halcox JP; Banegas JR; Roy C; Dallongeville J; De Backer G; Guallar E; Perk J; Hajage D; Henriksson KM; Borghi C
    BMC Cardiovasc Disord; 2017 Jun; 17(1):160. PubMed ID: 28623902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidemia and its association with meibomian gland dysfunction.
    Braich PS; Howard MK; Singh JS
    Int Ophthalmol; 2016 Aug; 36(4):469-76. PubMed ID: 26515235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Cardiorespiratory Fitness Levels on the Risk of Developing Atherogenic Dyslipidemia.
    Breneman CB; Polinski K; Sarzynski MA; Lavie CJ; Kokkinos PF; Ahmed A; Sui X
    Am J Med; 2016 Oct; 129(10):1060-6. PubMed ID: 27288861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between atherogenic dyslipidemia and recurrent stroke risk in patients with different subtypes of ischemic stroke.
    Zhao L; Wang R; Song B; Tan S; Gao Y; Fang H; Lu J; Xu Y
    Int J Stroke; 2015 Jul; 10(5):752-8. PubMed ID: 25924059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid assessment and treatment patterns in hospitalized TIA and ischemic stroke patients.
    Ovbiagele B; Hills NK; Saver JL; Johnston SC;
    J Hosp Med; 2006 Jul; 1(4):214-20. PubMed ID: 17219502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care.
    Bestehorn K; Smolka W; Pittrow D; Schulte H; Assmann G
    Curr Med Res Opin; 2010 Dec; 26(12):2833-9. PubMed ID: 21058895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenic dyslipidemia in patients with established coronary artery disease.
    Lahoz C; Mostaza JM; Tranche S; Martin-Jadraque R; Mantilla MT; López-Rodriguez I; Monteiro B; Sanchez-Zamorano MA; Taboada M
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):103-8. PubMed ID: 20675108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Atherogenic Index of Plasma is Independently Associated with Symptomatic Carotid Artery Stenosis.
    Garg R; Knox N; Prasad S; Zinzuwadia S; Rech MA
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105351. PubMed ID: 33045624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.